ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by Martingale Asset Management L P

Martingale Asset Management L P raised its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1,100.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,800 shares of the medical instruments supplier’s stock after purchasing an additional 15,400 shares during the quarter. Martingale Asset Management L P owned 0.07% of ICU Medical worth $2,607,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Invesco Ltd. grew its position in ICU Medical by 12.4% in the 4th quarter. Invesco Ltd. now owns 113,153 shares of the medical instruments supplier’s stock valued at $17,558,000 after buying an additional 12,489 shares during the last quarter. Bank of Montreal Can lifted its stake in shares of ICU Medical by 5.4% in the 4th quarter. Bank of Montreal Can now owns 4,051 shares of the medical instruments supplier’s stock worth $629,000 after acquiring an additional 208 shares during the period. Russell Investments Group Ltd. boosted its holdings in shares of ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock valued at $99,000 after acquiring an additional 300 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of ICU Medical during the fourth quarter worth about $202,000. Finally, Wells Fargo & Company MN raised its holdings in ICU Medical by 25.9% during the fourth quarter. Wells Fargo & Company MN now owns 13,543 shares of the medical instruments supplier’s stock worth $2,101,000 after purchasing an additional 2,784 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Raymond James set a $97.00 price objective on ICU Medical in a report on Wednesday, March 12th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, April 4th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Tuesday. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $168.67.

ICU Medical Trading Down 8.3 %

Shares of ICUI opened at $138.43 on Friday. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.39 billion, a P/E ratio of -30.29 and a beta of 0.86. The firm’s 50-day moving average is $148.66 and its two-hundred day moving average is $161.17.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.